Vertex Pharmaceuticals Inc. (VRTX): Price and Financial Metrics

VRTX POWR Grades

• Quality is the dimension where VRTX ranks best; there it ranks ahead of 97.49% of US stocks.
• The strongest trend for VRTX is in Quality, which has been heading down over the past 177 days.
• VRTX's current lowest rank is in the Momentum metric (where it is better than 39.79% of US stocks).

VRTX Stock Summary

• VRTX has a higher market value than 97.45% of US stocks; more precisely, its current market capitalization is $82,403,089,921.
• Of note is the ratio of VERTEX PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 11.57% of US stocks have a lower such ratio.
• With a price/sales ratio of 9.47, VERTEX PHARMACEUTICALS INC has a higher such ratio than 87.62% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to VERTEX PHARMACEUTICALS INC are MU, LRCX, REGN, AMAT, and INTC.
• VRTX's SEC filings can be seen here. And to visit VERTEX PHARMACEUTICALS INC's official web site, go to www.vrtx.com.

VRTX Valuation Summary

• VRTX's EV/EBIT ratio is 17.4; this is 75.76% higher than that of the median Healthcare stock.
• VRTX's price/sales ratio has moved up 2.6 over the prior 243 months.

Below are key valuation metrics over time for VRTX.

VRTX Growth Metrics

Its 3 year cash and equivalents growth rate is now at 162.63%.
• Its year over year net cashflow from operations growth rate is now at -20.25%.
• Its 2 year net cashflow from operations growth rate is now at 30.02%.

VRTX's revenue has moved up $4,537,740,000 over the prior 33 months.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	8,700.561	4,046.493	3,273.21
2022-06-30	8,350.425	4,018.212	3,194.638
2022-03-31	7,947.595	2,678.645	2,451.062
2021-12-31	7,574.4	2,643.5	2,342.1
2021-09-30	7,129.659	2,140.039	2,176.18
2021-06-30	6,683.766	2,120.568	1,991.686

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VRTX has a Quality Grade of B, ranking ahead of 86.88% of graded US stocks.
• VRTX's asset turnover comes in at 0.564 -- ranking 66th of 681 Pharmaceutical Products stocks.
• ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.